Renovaro Inc. financial data

Symbol
RENB on Nasdaq
Industry
Pharmaceutical Preparations
Location
Century City Medical Plaza, 2080 Century City East, Suite 906 Los Angeles, CA
State of incorporation
DE
Fiscal year end
June 30
Former names
RENOVARO BIOSCIENCES INC. (to 2/7/2024), Enochian Biosciences Inc (to 8/1/2023), DanDrit Biotech USA, Inc. (to 2/23/2018), Putnam Hills Corp. (to 2/11/2014)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.6 % -72.4%
Debt-to-equity 27.7 % +29%
Return On Equity -113 % -55.9%
Return On Assets -88.8 % -48.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 156M shares +138%
Common Stock, Shares, Outstanding 158M shares +140%
Entity Public Float 57.2M USD +25.9%
Common Stock, Value, Issued 15.8K USD +140%
Weighted Average Number of Shares Outstanding, Basic 157M shares +143%
Weighted Average Number of Shares Outstanding, Diluted 157M shares +143%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.53M USD +19.1%
General and Administrative Expense 21.6M USD +13.2%
Operating Income (Loss) -126M USD -213%
Nonoperating Income (Expense) 10.4M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.18M USD -19.2%
Net Income (Loss) Attributable to Parent -116M USD -181%
Earnings Per Share, Basic -0.98 USD/shares -38%
Earnings Per Share, Diluted -0.98 USD/shares -38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 221K USD -57.9%
Cash, Cash Equivalents, and Short-term Investments 91.4K USD -97.6%
Assets, Current 1.95M USD +2.2%
Property, Plant and Equipment, Net 452K USD -6.28%
Operating Lease, Right-of-Use Asset 1.15M USD +33.2%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Goodwill 118M USD +915%
Other Assets, Noncurrent 119M USD +116%
Assets 122M USD +112%
Accrued Liabilities, Current 5.36M USD +572%
Liabilities, Current 23M USD +128%
Operating Lease, Liability, Noncurrent 710K USD -1.46%
Other Liabilities, Noncurrent 231K USD +25.3%
Liabilities 23.7M USD +120%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6.3M USD
Retained Earnings (Accumulated Deficit) -369M USD -45.7%
Stockholders' Equity Attributable to Parent 98.1M USD +110%
Liabilities and Equity 122M USD +112%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.02M USD +27.4%
Net Cash Provided by (Used in) Financing Activities 2.03M USD -20.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 350M shares +250%
Common Stock, Shares, Issued 158M shares +140%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.35M USD -12.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 221K USD -57.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 169M USD +16.6%
Depreciation 114K USD +5.82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -109M USD -165%
Lessee, Operating Lease, Liability, to be Paid 1.34M USD +37.9%
Property, Plant and Equipment, Gross 1.06M USD +8.9%
Operating Lease, Liability, Current 504K USD +136%
Lessee, Operating Lease, Liability, to be Paid, Year Two 458K USD +80.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 554K USD +125%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 91K USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 335K USD +28.3%
Deferred Tax Assets, Operating Loss Carryforwards 144M USD +2.59%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 309K USD
Operating Lease, Payments 108K USD +9.59%
Additional Paid in Capital 461M USD +53.6%
Preferred Stock, Shares Outstanding 0 shares -100%
Operating Leases, Future Minimum Payments, Due in Two Years 246K USD -17.5%
Amortization of Intangible Assets 8.3K USD +34.3%
Depreciation, Depletion and Amortization 127K USD +13%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 60K USD -31.6%
Share-based Payment Arrangement, Expense 465K USD -43.2%
Operating Leases, Future Minimum Payments, Due in Three Years 253K USD +3%
Operating Leases, Future Minimum Payments Due 1.04M USD -21.2%
Interest Expense 304K USD +148%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%